Modulation of gene expression by combination therapy

Details Modulation of gene expression by combination therapy Modulation of gene expression by combination therapy

2005-10-11

2005-10-11

Lacourciere, Karen A. (Department: 1635)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C435S006120, C435S091100, C435S455000, C435S375000, C536S023100, C536S024500

Reexamination Certificate

active

06953783

ABSTRACT:
The invention relates to the modulation of gene expression. In particular, the invention relates to compositions comprising antisense oligonucleotides which inhibit expression of a gene in operable association with protein effectors of a product of that gene, and methods of using the same.In addition, the invention relates to the modulation of mammalian gene expression regulated by methylation.

REFERENCES:
patent: 5578716 (1996-11-01), Szyf et al.
patent: 6268137 (2001-07-01), Szyf et al.
patent: WO 94 08625 (1994-04-01), None
patent: WO94/08625 (1994-04-01), None
patent: WO97/32589 (1997-09-01), None
patent: WO 97 32589 (1997-09-01), None
patent: WO 97 32604 (1997-09-01), None
patent: WO97/32604 (1997-09-01), None
patent: WO 97 35990 (1997-10-01), None
patent: WO97/44346 (1997-11-01), None
patent: WO 97/44346 (1997-11-01), None
patent: WO 99 15648 (1999-04-01), None
Fournel et al. Journal of Biological Chemistry. August 20, 1999, vol. 274, No. 34, pp. 24250-24256.
Branch, A. D. A good antisense molecule is hard to find. Feb. 1998. TIBS vol. 23, pp. 45-50.
Crooke, S. T. Antisense Research and Application, Chapter 1, Basic Principles of Antisense Therapeutics, (1998) pp. 1-50. Springer-Verlag Press. Berlin. Heidelberg, New York.
Jen et al. Suppression of Gene Expression by Targeted Disruption of Messenger RNA: Available Options and Current Stategies. (2000) Stem Cells. vol. 18, pp. 307-319.
Ju et al. “Increased Drug Sensitivity of Tumor Cells by Manipulation of Cell Cycle Control Genes.” (Jan. 1996), Thesis, University of Southern California, pp. 100-130.
Szyf, M., Pharmacol. Ther. vol. 70, No. 1, 1996, “The DNA Methylation Machinery as a Target for Anticancer Therapy”, pp. 1-37.
Szyf, M. et al., The Journal of Biological Chemistry, vol. 267, No. 15, 1992, “Induction of Myogenic Differentiation by an Expression Vector Encoding the DNA Methyltransferase cDNA sequence in the Antisense Orientation”, pp. 12831-12836.
MacLeod, A. R. et al., The Journal of Biological Chemistry, vol. 270, No. 14, 1995, “Expression of Antisense to DNA Methyltransferase mRNA Induces DNA Demethylation and Inhibits Tumorigenesis”, pp. 8037-8043.
Wu, J.C. et al., The Journal of Biological Chemistry, vol. 262, No. 10, 1987, “Kinetic and Catalytic Mechanism of Hhal Methyltransferase”, pp. 4778-4786.
Bestor, T. et al., J. Mol. Biol., vol. 203, 1988, “Cloning and Sequencing of a cDNA Encoding DNA Methyltransferase of Mouse Cells: The Carboxyl-terminal Domain of the Mammalian Enzymes is Related to Bacterial Restriction Methyltransferases”, pp. 971-983.
Yen, R.W.C. et al., Nucleic Acide Research, vol. 20, No. 9, 1992, “Isolation and characterization of the cDNA encoding human DNA methyltransferase”, pp. 2287-2291.
Yoder, J.A. et al., The Journal of Biological Chemistry, vol. 271, No. 49, 1996, “New 5′ Regions of the Murine and Human Genes for DNA (Cytosine-5)-methyltransferase”, pp. 31092-31097.
Ju et al., “Increased Drug Sensitivity of Tumor Cells by Manipulation of Cell Cycle Control Genes”, Thesis University of Southern California, Jan. 1, 1996, pp. 100-130.
PCT International Search Report, International Application No. PCT/US99/24278: Date of Completion: Mar. 22, 2000, Date of Mailing: Mar. 29, 2000. Authorized Officer: Leherte, C. (5 pages).
Ju et al., “Increased Drug Sensitivity of Tumor Cells by manipulation of Cell Cycle Control Genes”, Thesis Univ. So. California, pp. 100-130, 1996.
Amer. Assoc. for Cancer Res.: Proceedings of the 89thAnnual Meeting of the Am. Assoc. for Cancer Res., New Orleans, 39:416 XP002094749, 1998.

Affiliated with

Also associated with

Rating

Modulation of gene expression by combination therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulation of gene expression by combination therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of gene expression by combination therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3437850